VIOT · Viomi Technology Co., Ltd

Current Thesis

Viomi Technology’s recovery now depends on improving appliance sales and restoring profit after its Nasdaq compliance catalyst resolved; the next financial results must establish that improvement before the market loses the $0.99 research threshold. The remaining operating case is specific: second-half 2026 revenue above the reported first-half RMB740.0 million and positive net income. This is an inference about a possible recovery, not a reported result.

The company announced on 2026-09-18 that Nasdaq’s letter dated 2026-09-17 confirmed regained compliance after qualifying closing bids during 2026-09-02 through 2026-09-16. The original compliance event has therefore occurred. In research terms, the narrative is maturing — the anticipated regulatory confirmation arrived on 2026-09-18, while operating recovery remains unverified. Company compliance announcement

The new complication is financing capacity: a 2026-09-08 amended registration statement proposed up to US$100 million of securities offerings. That preliminary filing establishes potential issuance capacity, not completed issuance or proceeds. Together with the already-resolved catalyst, it leaves a low-conviction operating-recovery case. Form F-3/A

Bullish and bearish views on Viomi Technology Co., Ltd

The model's bull view on Viomi Technology Co., Ltd (VIOT), in brief: Cash supports the recovery case. Viomi reported cash and equivalents of RMB603.8 million, translated as US$89.0 million, at 2026-06-30. This is a dated balance-sheet resource; no updated market-capitalisation comparison is established here. 2026-08-27 results Consumables… The bear view: Operating recovery remains unproven. First-half 2026 revenue fell 49.9% year over year to RMB740.0 million, and the company reported a RMB26.3 million net loss. Management attributed the contraction partly to subsidy withdrawal; its description of demand weakness as temporary… Both cases follow in full.

Bull Case

• Cash supports the recovery case. Viomi reported cash and equivalents of RMB603.8 million, translated as US$89.0 million, at 2026-06-30. This is a dated balance-sheet resource; no updated market-capitalisation comparison is established here. 2026-08-27 results
• Consumables retained revenue growth. First-half 2026 consumables revenue reached RMB131.7 million, up 6.9% year over year, despite the contraction in equipment sales. That segment supplies a measurable source of resilience. 2026-08-27 results
• Repurchases demonstrate actual capital return. The 2026-08-27 release reported approximately US$3.8 million spent on repurchases through 2026-06-30, with US$16.2 million authorised but unspent. The remaining authorisation does not establish continuing market purchases. Company results

Bear Case

• Operating recovery remains unproven. First-half 2026 revenue fell 49.9% year over year to RMB740.0 million, and the company reported a RMB26.3 million net loss. Management attributed the contraction partly to subsidy withdrawal; its description of demand weakness as temporary remains management’s view. 2026-08-27 results
• Financing could expand share supply. The 2026-09-08 preliminary registration covers up to US$100 million across several security types. A subsequent offering document specifying equity issuance would establish the terms of dilution; the amendment alone does not. Form F-3/A
• Restricted cash remains separate. Viomi disclosed RMB153.3 million of restricted cash at 2026-06-30 separately from cash and equivalents. It cannot be treated as additional freely available cash. 2026-08-27 results

Setup & Price Structure

The adjusted daily close was $1.29 on 2026-09-18. The supplied market series records a three-month gain of 51.7%, while the shares remained 61.5% below their 52-week high of $3.35. These observations establish a recovery within a larger decline; they do not establish an operating turnaround.

The 14-period relative strength index was 59.2 on 2026-09-18. No moving-average value, trading-volume series or short-interest measurement accompanies that observation, so neither distance above trend nor squeeze participation can be assessed.

Benzinga’s supplied headline record contains consumer-discretionary mover roundups dated 2026-09-10 and 2026-09-16. This is evidence of recurring market-movement coverage. The sample is too small to support a claim about retail crowding, broadening ownership or sentiment saturation.

The $0.99 threshold is a research boundary beneath the $1.00 minimum-bid reference discussed in Viomi’s 2026-09-18 announcement, not a demonstrated chart shelf. An adjusted weekly close below that research threshold would invalidate the residual recovery case; it would not by itself establish a new Nasdaq deficiency.

Catalyst Calendar (next 30 days)

For 2026-09-20 through 2026-10-20, no dated company catalyst is confirmed in the reviewed investor-relations calendar and announcements. The September compliance announcement is completed, and the former 2027-01-19 cure deadline is no longer an unresolved catalyst. Investor relations

• ~2027-03-25, estimated financial results. This remains an unconfirmed estimate for second-half and full-year 2026 results, using the 2026-03-25 annual release as the calendar reference. This later event is included because revenue recovery and profitability are the remaining thesis tests; the company has not announced that reporting date. Financial-results archive

What Would Change Our Mind

Loss of the recovered minimum-bid region would break the market component of the thesis: a weekly close below $0.99 is the published invalidation condition. This is a price-based research test, separate from Nasdaq’s determination of listing compliance.

The operating case reaches its stated outcome only if the next results report second-half 2026 revenue above the first-half RMB740.0 million and positive net income before that price condition fires. Revenue at or below that reported benchmark, or another net loss, would reject the proposed operating recovery. The benchmark comes from Viomi’s 2026-08-27 results; improvement has not yet been reported.

Correlation Notes

This is a single-company recovery case. The 2026-09-18 compliance announcement and 2026-09-08 financing registration are issuer-specific events; neither establishes participation in a broader equity theme.

Management’s 2026-08-27 explanation links appliance demand to Chinese subsidy policy. That is an identified business exposure, not a measured share-price correlation. No paired return series is available here to establish a relationship with Chinese equities, consumer-discretionary benchmarks or currency movements.